Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21764738 | 0.81 | MEN1 (0.33) | MEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL21764584 | 0.80 | — | — | |
| SCHEMBL21764595 | 0.78 | TSHR (0.36) | TSHRLAP3CYP3A4GAAMEN1 | |
| SCHEMBL21764583 | 0.73 | ALDH1A1 (0.35) | TSHRCYP3A4MEN1KMT2AALDH1A1 | |
| SCHEMBL21764561 | 0.72 | TSHR (0.39) | TSHRALDH1A1TDP1 | |
| SCHEMBL11860467 | 0.72 | TSHR (0.32) | TSHR | |
| SCHEMBL21764713 | 0.71 | CYP3A4 (0.48) | TSHRCYP3A4ALDH1A1 | |
| SCHEMBL21764749 | 0.71 | BTN3A1 (0.47) | ALDH1A1 | |
| SCHEMBL4609160 | 0.70 | TSHR (0.40) | TSHRLAP3CYP3A4GAAMEN1 | |
| SCHEMBL21764589 | 0.69 | LPAR3 (0.50) | TSHRCYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3474860-B1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE | AEQUOR INC (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20200060280-A1 | Antimicrobial Compounds and Methods of Use | AEQUOR, INC. | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200060280-A1 | Antimicrobial Compounds and Methods of Use | DDT, PFAS, DSTN | TSHR 1132/4885LAP3 2454/4885CYP3A4 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.